Cristina Larkin

COO

Spero Therapeutics, Inc. (SPRO)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Spero Therapeutics, Inc. (SPRO)
COO

Proxy statement

Current

Company network

Recorded roles and earnings-call appearances connecting this person to public companies.

Spero Therapeutics, Inc.

SPRO

Current role

COO

8 calls Latest call 2022-03-31

View earnings calls

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2021	Spero Therapeutics, Inc. (SPRO)	Former Chief Operating Officer	$460,406	—	$399,994	$848,983	$185,107	$9,440	$1,903,930
2020	Spero Therapeutics, Inc. (SPRO)	Former Chief Operating Officer	$404,052	—	—	$352,600	$225,968	$9,342	$991,962

Recent activity

Earnings-call appearances and filed executive appointments or departures, newest first.

Earnings call Spero Therapeutics, Inc. Q4 FY2021 Earnings Call Spero Therapeutics, Inc. (SPRO)
2022-03-31
Earnings call Spero Therapeutics, Inc. Q3 FY2021 Earnings Call Spero Therapeutics, Inc. (SPRO)
2021-11-10
Earnings call Spero Therapeutics, Inc. Q2 FY2021 Earnings Call Spero Therapeutics, Inc. (SPRO)
2021-08-05
Earnings call Spero Therapeutics, Inc. Q1 FY2021 Earnings Call Spero Therapeutics, Inc. (SPRO)
2021-05-06
Earnings call Spero Therapeutics, Inc. Q4 FY2020 Earnings Call Spero Therapeutics, Inc. (SPRO)
2021-03-11
Earnings call Spero Therapeutics, Inc. Q3 FY2020 Earnings Call Spero Therapeutics, Inc. (SPRO)
2020-11-05
Earnings call Spero Therapeutics, Inc. Q2 FY2020 Earnings Call Spero Therapeutics, Inc. (SPRO)
2020-08-06
Earnings call Spero Therapeutics, Inc. Q1 FY2020 Earnings Call Spero Therapeutics, Inc. (SPRO)
2020-05-08